Mubadala’s ‘KELIX bio’ acquires ‘DiabTec’

KELIX bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec LLC, a subsidiary of Julphar.This acquisition strengthens Mubadala's portfolio of biologicals, establishes its role in biomanufacturing across the MENA region, and supports ...